Ultragenyx Pharmaceutical Inc. buy HC Wainwright
Start price
14.02.25
/
50%
€40.20
Target price
14.02.26
€90.54
Performance (%)
-27.36%
Price
23.12.25
€29.20
Summary
This prediction is currently active. The prediction for Ultragenyx Pharmaceutical Inc. disappoints with a performance of -27.36%. This prediction currently runs until 14.02.26. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 0.000% | 0.000% |
| iShares Core DAX® | 0.323% | 2.208% |
| iShares Nasdaq 100 | 0.145% | -0.987% |
| iShares Nikkei 225® | 0.091% | -1.421% |
| iShares S&P 500 | 0.371% | -0.469% |
Comments by HC_Wainwright for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $95.00 price target on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by HC_Wainwright for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€27.00
09.09.25
09.09.25
€67.95
09.09.26
09.09.26
-37.78%
23.12.25
23.12.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€23.80
28.07.25
28.07.25
€68.10
28.07.26
28.07.26
-29.41%
23.12.25
23.12.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€42.00
24.12.24
24.12.24
€91.30
24.12.25
24.12.25
-60.71%
25.12.25
25.12.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€48.20
06.11.24
06.11.24
€88.68
06.11.25
06.11.25
-44.40%
07.11.25
07.11.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€38.80
01.08.23
01.08.23
€74.73
01.08.24
01.08.24
3.09%
02.08.24
02.08.24

